The Promises and Perils of Real Options Valuation Technique.

Mayank Gupta

ISBN 10: 3844310037 / ISBN 13: 9783844310030

Edité par LAP LAMBERT Academic Publishing Feb 2011, 2011

A propos de cet article

Neuware -This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry.Books on Demand GmbH, Überseering 33, 22297 Hamburg 76 pp. Englisch. N° de réf. du vendeur 9783844310030

Détails bibliographiques

Titre : The Promises and Perils of Real Options ...

Éditeur : LAP LAMBERT Academic Publishing Feb 2011

Date d'édition : 2011

Reliure : Taschenbuch

Etat : Neu

A propos de ce titre

Synopsis :

This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry.